Hall v. Pfizer, Inc.

Full title: JAMES HALL, et al., Plaintiffs, v. PFIZER, INC., Defendant

Court: United States District Court, D. New Jersey

Date published: May 18, 2006

Civil Action No. 06-2216 (MLC) (D.N.J. May. 18, 2006)

Opinion

Civil Action No. 06-2216 (MLC).

May 18, 2006

MEMORANDUM OPINION

MARY COOPER, District Judge

THE PLAINTIFFS bringing this action (1) inter alia, to recover damages for injuries suffered from ingesting a pharmaceutical product known as Celebrex (Compl.), and (2) in state court on April 10, 2006; and the defendant removing the action under 28 U.S.C. § 1332 on May 16, 2006 ("Removed Action") (dkt. entry no. 1); and the Court noting that the plaintiffs have brought a separate action against the defendant in this Court ("Federal Action") (see Civil Action No. 06-1878 (MLC), dkt. entry no. 1, 4-19-06 Compl.); and it appearing that the complaints in both actions assert identical claims; and thus the Court intending to dismiss the complaint in the Removed Action as being duplicative; but the Court advising the parties that this dismissal shall not be construed as being a determination on the merits of the claims in the Federal Action; and for good cause appearing, the Court will issue an appropriate order and judgment.